NCT05617560 is a NA clinical trial of Telemedical care in Telemedicine, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT05617560?

NCT05617560 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT05617560?

Interventions in NCT05617560: Telemedical care.

What condition does NCT05617560 study?

NCT05617560 studies Telemedicine.

Is NCT05617560 still recruiting?

NCT05617560 is currently completed. Last updated 11 April 2025.

Last reviewed 2025-04-11 · How we verify

NCT05617560

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hospital@Home: Telemedical Care After Inpatient Hospital Stay

Completed NA Last updated 11 April 2025

What this trial tests

NA trial testing Telemedical care in Telemedicine in 234 participants. Completed in 31 December 2024.

Timeline

26 October 2022

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	234
Start date	26 October 2022
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Switzerland

Drugs / interventions tested

Telemedical care

Conditions studied

Telemedicine — all drugs for Telemedicine →

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Telemedicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine. Throughout the study, patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success. Overall, new information flow and communication between the stakeholders (hospital, telemedicine and general practitioners) are defined and tested. The Hospital@Home pilot study is intended to become a flagship project for new healthcare models.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluating a Telemedical Follow-Up Program for Continuity of Care After Hospital Discharge: Prospective Clinical Intervention Study.
Gram JS, Meier R, Hölz B, Abdelhamid K, et al · · 2026 · PMID 41894547 · DOI 10.2196/85467

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05617560 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 11 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05617560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing